• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

August 3, 2023

Military-Related Traumatic Brain Injury a Risk Factor for New-Onset Mental Health Conditions

Author(s):

Luke Halpern, Assistant Editor

The risk of death by suicide in soldiers was both directly and indirectly related to traumatic brain injury through confounding mental health diagnoses.

Among soldiers with a history of military-related traumatic brain injury (TBI), there were high rates of new-onset mental health diagnoses, in addition to being both directly and indirectly associated with a risk of suicide, according to the results of a study published in the Journal of the American Medical Association.

Image credit: DedMityay - stock.adobe.com

Image credit: DedMityay - stock.adobe.com

The cohort study gathered data from the Substance Use and Psychological Injury Combat Study (SUPIC), a database including soldiers returning from combat operations between 2008 and 2014. Soldiers were followed-up with from the end of their first deployment during the study window.

Diagnoses for mental health were grouped into 6 categories: mood, anxiety, alcohol use, adjustment, substance use (excluding alcohol and tobacco), and posttraumatic stress disorders. Investigators identified Mortality Data Repository records to determine death by suicide.

A sample of 860,892 soldiers (320,539 soldiers [37.2%] aged 18-24 years at end of index deployment; 766,454 [89.0%] male) were included in the study. Of these, 108,785 (12.6%) had a history of TBI.

Among soldiers who had a history of TBI, 458 (0.4%) died by suicide, compared to 2237 soldiers (0.3%) who did not have a history of TBI, the study found. Mental health diagnoses were higher for soldiers with a history of TBI compared to those without. Investigators also observed higher increases in rates of mental health diagnoses from before to after TBI or match dates in soldiers with TBI.

Among soldiers who had mood disorder diagnoses, soldiers with TBI had an increase from 24,460 soldiers (22.5%) before the TBI to 40,997 soldiers (37.7%) following the TBI, a 67.7% increase, compared to a 37.5% increase among those who did not have TBI.

Furthermore, soldiers with a history of TBI had a 31.9% increase in alcohol use disorders compared to those without a history of TBI, who only had a 10.3% increase. The largest observed disparity was for substance use disorders (SUDs), as soldiers with a history of TBI had a 100% increase compared to a 14.5% increase among those without TBI.

Notably, the time to suicide for those with a history of TBI was 21.3% faster (deceleration factor, 0.787; 95% CI, 0.715-0.866) than those without a history of TBI. Researchers determined a direct effect estimate of TBI on suicide, which ranged from an 8.5% faster time to suicide for soldiers with TBI (deceleration factor, 0.915; 95% CI, 0.829-1.010) than those without a TBI for the 2 or more mental health diagnoses model, to a time to suicide for soldiers with TBI 16.7% faster (deceleration factor, 0.833; 95% CI, 0.756-0.918) than those without a TBI for the adjustment disorder model, the researchers determined.

In examining indirect associations between TBI and suicide, investigators found the largest indirect effect estimate was observed for the substance use model. Soldiers with TBI had a 62.8% faster (deceleration factor, 0.372; 95% CI, 0.322-0.433) time to suicide through the appearance of a new-onset SUD, in comparison to soldiers without TBI.

Many prior studies focused on highlighting the association between TBI and suicide without considering whether mental health conditions could affect this association. However, these new findings that TBI and suicide are both directly and indirectly related—through new-onset mental health diagnoses—shows the importance of rethinking methodologies to increase understanding, the study authors discussed.

“These findings support adopting methodological strategies aimed at evaluating risk over an individual’s lifetime, with a focus on how events and conditions accumulate both proximally and distally,” the investigators concluded.

Reference

Brenner LA, Forster JE, Gradus JL, et al. Associations of military-related traumatic brain injury with new-onset mental health conditions and suicide risk. JAMA Netw Open. 2023;6(7):e2326296. doi:10.1001/jamanetworkopen.2023.26296

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Psychiatric pharmacist and patient -- Image credit: NanSan | stock.adobe.com
Psychiatric pharmacist -- Image credit: HBS | stock.adobe.com
Related Content
Advertisement
elbow bones injury - Image credit: SoftSheep | stock.adobe.com
July 15th 2025

Type 2 Diabetes and Obesity in Teens Could Increase Risk of Osteoporosis

Kennedy Ferruggia, Assistant Editor
COBRRA Trial Results Raise Questions About VTE Management
July 15th 2025

COBRRA Trial Results Raise Questions About VTE Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Insulin and syringe | Image Credit: © Sherry Young - stock.adobe.com
July 15th 2025

Insulin Aspart-xjhz Becomes First Interchangeable Biosimilar Rapid-Acting Insulin

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Health care professional preparing a vaccine -- Image credit: REDPIXEL | stock.adobe.com
July 15th 2025

Study: Recommendations From Health Care Professionals Improve Immunization Rates Among Patients With CKD

Gillian McGovern, Associate Editor
Respiratory Virus Genetic Material Micrograph - Image credit: GOLVR | stock.adobe.com
July 15th 2025

Targeting the Integrated Stress Response Through a Platform for Antiviral Drug Discovery Against Zika, Herpes, and RSV

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
elbow bones injury - Image credit: SoftSheep | stock.adobe.com
July 15th 2025

Type 2 Diabetes and Obesity in Teens Could Increase Risk of Osteoporosis

Kennedy Ferruggia, Assistant Editor
COBRRA Trial Results Raise Questions About VTE Management
July 15th 2025

COBRRA Trial Results Raise Questions About VTE Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Insulin and syringe | Image Credit: © Sherry Young - stock.adobe.com
July 15th 2025

Insulin Aspart-xjhz Becomes First Interchangeable Biosimilar Rapid-Acting Insulin

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Health care professional preparing a vaccine -- Image credit: REDPIXEL | stock.adobe.com
July 15th 2025

Study: Recommendations From Health Care Professionals Improve Immunization Rates Among Patients With CKD

Gillian McGovern, Associate Editor
Respiratory Virus Genetic Material Micrograph - Image credit: GOLVR | stock.adobe.com
July 15th 2025

Targeting the Integrated Stress Response Through a Platform for Antiviral Drug Discovery Against Zika, Herpes, and RSV

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.